Publisher： John Wiley & Sons Inc
E-ISSN： 1365-2265|83|4|475-482
ISSN： 0300-0664
Source： CLINICAL ENDOCRINOLOGY, Vol.83, Iss.4, 2015-10, pp. : 475-482
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
SummaryObjectiveTo investigate the effects of long‐term effective control of serum uric acid on renal function in patients with type 2 diabetes and asymptomatic hyperuricemia.MethodsApplication of randomized open parallel‐controlled methods, a total of 176 patients with type 2 diabetes and asymptomatic hyperuricemia were selected, and was randomly divided into two groups for allopurinol or conventional treatments, respectively. Changes in urinary albumin excretion rate (UAER), the levels of serum creatinine and glomerular filtration rate (GFR) and the incidence of new‐onset diabetic nephropathy (DN) and hypertension in patients before and after 3 years of treatment were measured and compared between groups.ResultsThere were no statistically significant difference in the baseline clinical characteristics of study participants between two treatment groups (P > 0·05 for all). After 3 years of treatment, compared to the conventional treatment, the allopurinol treatment was more effective in reducing serum uric acid, UAER, serum creatinine (P < 0·01 for all) and increasing GFR (P < 0·01). The intention‐to‐treat (ITT) analysis indicated that the incidence of new‐onset DN and hypertension in the allopurinol group showed a declining trend compared to that in the conventional treatment group, despite a lack of significant difference (P > 0·05).ConclusionLong‐term effective control of serum uric acid can decrease UAER and serum creatinine, increase GFR and may exert kidney protection effects in patients with type 2 diabetes and asymptomatic hyperuricemia.
Related content
Access to resources
Recommend
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 6, 2015-07 ,pp. :
DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 2, 2015-02 ,pp. :
DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 3, 2015-03 ,pp. :